Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Estrogen metabolism shunting and detoxification pathway tuning

Estrogen Metabolism & Clearance · Endocrine function, hormone axes and circadian rhythm

Induces CYP1A1 to hydroxylate estradiol toward the less active, protective 2-OHE1, suppresses formation of the highly mutagenic 4-OHE1 and 16α-OHE1, and supports excretion through glucuronidation.

Why it matters: Improves estrogen dominance, lowers the risk of endometrial and breast hyperplasia, and eases premenstrual syndrome (PMS).

Molecular targets: CYP1A1, Competitive CYP1B1 inhibition, β-glucuronidase inhibition, COMT methyl transfer

Supplements acting on this mechanism (ranked by strength and evidence)

Diindolylmethane (DIM)

★★★☆☆Mechanism evidence: grade A

DIM can raise the urinary ratio of 2-hydroxyestrone to 16α-hydroxyestrone. This change in the metabolite ratio cannot on its own prove a specific enzyme pathway, a lower cancer risk or a clinical detox benefit. Its meaning is still unclear.

Calcium D-glucarate (CDG)

★★★☆☆Mechanism evidence: grade C

CDG is converted into a lactone in the gut, which can inhibit some bacterial β-glucuronidase. This effect has been seen in rat experiments. There is no reliable evidence that it changes estrogen excretion in humans, and the CYP1A1 shunt described on product labels has not been confirmed.

Schisandra chinensis standardized extract

★☆☆☆☆Mechanism evidence: grade D

In in-vitro studies with human liver cells, Schisandra chinensis extract can inhibit CYP3A4/5 metabolism while inducing CYP3A4 mRNA. These results concern drug-metabolizing enzymes. Shifts in estrogen metabolic pathways were not measured in humans, so the results cannot show that it supports estrogen detoxification.

Open in the interactive app ›